BHRT Evaluation for Shift Workers: A Complete Guide

Low Energy, Poor Sleep, Slow Recovery: What a BHRT Evaluation Actually Looks Like for Shift Workers

Abstract

Low energy, poor sleep, reduced libido, body-composition changes, and slow recovery can make shift workers wonder whether hormones are the problem. Sometimes hormones are the problem; often, the situation is more complicated. A responsible BHRT evaluation uses history, medication review, targeted laboratory testing, risk screening, and shared decision-making. Treatment should follow evidence of a clinically relevant hormonal issue, not become an automatic anti-aging prescription.

A data center technician finishes a third overnight shift feeling drained. Workouts recover slowly. Sleep is broken. Libido has changed. An IT professional on rotating schedules notices similar changes and asks, “Are my hormones off?”

That question deserves more than a quick blood draw.

Fatigue, sleep disruption, reduced sexual interest, and body-composition changes can occur with hormonal disorders, but they can also come from circadian disruption, anemia, thyroid disease, metabolic problems, under-fueling, medication effects, sleep apnea, chronic pain, or overwork. Shift work itself can produce insomnia or excessive sleepiness when work hours conflict with normal circadian timing (American Academy of Sleep Medicine [AASM], 2025). AASM

First, What Does “Bioidentical” Mean?

“Bioidentical” describes a hormone with a chemical structure that is identical to a hormone produced by the body. It does not automatically mean natural, safer, stronger, or more personalized. FDA-approved estradiol and micronized progesterone are examples. Compounded products may also contain bioidentical hormones, but compounded drugs do not undergo the same FDA premarket review for safety, effectiveness, quality, and standardized potency (American College of Obstetricians and Gynecologists [ACOG], 2023; U.S. Food and Drug Administration [FDA], 2026). ACOG

Diagnosis should come before marketing.

Step 1: Build the Symptom Timeline

A clinician starts by asking when symptoms began. For a shift worker, that history may include:

• current and previous work schedules;
• sleep timing on workdays and days off;
• snoring, breathing pauses, or morning headaches;
• caffeine, alcohol, nicotine, and energy-drink use;
• training volume, appetite, meal timing, and weight change;
• libido, menstrual or sexual changes, hot flashes, or night sweats;
• mood, stress, pain, and recovery time; and
• fertility goals when relevant.

The pattern matters. A worker exhausted only after several night shifts may need a different investigation than someone with persistent fatigue, low libido, and repeated hormonal abnormalities.

Step 2: Review Medications and Supplements

Medications, supplements, and substances can influence symptoms blamed on hormones. Sedating medicines may worsen fatigue; some antidepressants can affect sexual function; opioids can suppress reproductive hormone signaling. Other products can alter sleep, appetite, or laboratory results.

A careful evaluation records prescriptions, supplements, bodybuilding products, peptides, and previous hormone use so clinicians do not miss another explanation.

Step 3: Use Laboratory Testing to Answer Specific Questions

There is no universal “BHRT panel.” Testing should follow the history, examination, age, symptoms, and medical risks. Depending on the case, clinicians may consider:

• a complete blood count and iron studies;
• thyroid testing, often beginning with TSH;
• fasting glucose or hemoglobin A1C;
• kidney and liver markers;
• lipid testing;
• nutrient testing when indicated; and
• hormone measurements appropriate to the suspected condition.

A complete blood count is a standard tool for identifying anemia, while TSH is commonly the first blood test used to evaluate thyroid function (National Heart, Lung, and Blood Institute [NHLBI], 2025; National Institute of Diabetes and Digestive and Kidney Diseases [NIDDK], 2017). NHLBI, NIH

For men being evaluated for testosterone deficiency, symptoms alone are not enough. The Endocrine Society recommends diagnosis only when compatible symptoms or signs occur with unequivocally and consistently low testosterone, including repeat morning fasting testing and further evaluation of the cause (Bhasin et al., 2018; Endocrine Society, 2026). DOI

Step 4: Screen for Look-Alike Problems

Diagnostic literacy protects patients. Fatigue can come from anemia; sluggishness from hypothyroidism; and poor sleep from apnea or shift work disorder. Reduced recovery may follow under-fueling, excessive training, alcohol, pain, or insufficient sleep. Libido can also change with stress, mood, medications, or poor sleep.

For overnight NOC personnel, Amazon employees, and data center teams, schedules deserve special attention. Circadian misalignment can produce sleep disturbance and excessive sleepiness, and rotating schedules may make full circadian adaptation unrealistic (AASM, 2025). Treating a hormone number without addressing the sleep-work pattern can leave the main problem untouched. AASM

Step 5: Decide Whether Treatment Is Appropriate

If testing and clinical findings identify a meaningful hormonal problem, the next conversation is eligibility—not automatic treatment.

Risk screening depends on the hormone and patient. For menopausal therapy, clinicians consider age, time since menopause, cardiovascular or clotting risk, liver disease, hormone-sensitive cancer history, abnormal bleeding, and whether the uterus is present. Testosterone evaluation also considers fertility, hematocrit, prostate factors when appropriate, sleep apnea, and cardiovascular history.

Current guidance supports individualized benefit-risk assessment rather than a standardized approach (ACOG, 2023; Endocrine Society, 2018). ACOG

Step 6: Choose a Delivery Method for a Reason

When hormone therapy is appropriate, the route should match the diagnosis, goals, safety profile, and evidence. Depending on the indication, options may include patches or gels, oral preparations, vaginal therapy, injections, or other prescribed routes. The route can affect absorption, side effects, convenience, reversibility, and risk.

Patients should also understand the difference between FDA-approved products and compounded preparations. ACOG recommends FDA-approved menopausal hormone therapies over routinely compounded products when approved options meet the patient’s needs because compounded preparations can have variable potency and lack FDA premarket review (ACOG, 2023). Compounding can still have a role when a specific medical need cannot be met by an approved product. ACOG

Step 7: Follow the Patient, Not Just the Number

Starting therapy begins a monitoring phase. Follow-up may include symptom review, blood pressure, adverse effects, medication adherence, and repeat laboratory testing suited to the therapy. Testosterone treatment, for example, requires monitoring for clinical response and adverse effects, with laboratory and prostate-related follow-up as appropriate (Bhasin et al., 2018). DOI

The target is not an internet-promoted “optimal” number. The target is an appropriate range, meaningful symptom improvement, acceptable risk, and a treatment plan that still makes sense over time.

How the Integrated Team Fits Together

Dr. Maria Guadalupe Cardenas, MD, Board Certified in Internal Medicine with more than 40 years of experience, serves as Medical Director, Clinical Director, and Collaborative Physician at Injury Medical Clinic PA in El Paso. She provides medical oversight, risk stratification, laboratory interpretation, and coordination of systemic conditions.

Dr. Alex Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, bridges physical medicine with advanced medical diagnostics. As a Doctor of Chiropractic and Board-Certified Family Practice Nurse Practitioner, he connects rehabilitation, functional medicine nutrition, laboratory findings, and recovery patterns within the collaborative medical framework.

That integration matters because a shift worker may have several problems at once. Pain can disrupt sleep. Non-invasive rehabilitation may address mechanical strain without extra medication. Metabolic disease can reduce energy. Hormonal changes may be part of the picture, but they should not be examined in isolation.

What Patients Gain From a Careful Evaluation

A rigorous BHRT evaluation brings clarity. It can help patients:

• identify treatable causes of fatigue that might otherwise be missed;
• avoid unnecessary hormone exposure;
• understand why a laboratory value matters—or does not;
• compare treatment options accurately;
• coordinate care with other clinicians; and
• make informed choices about sleep, nutrition, rehabilitation, and medical therapy.

This supports beneficence by targeting the actual problem, non-maleficence by reducing unnecessary medication or procedure risk, and autonomy by giving patients understandable evidence before they choose a path.

A Better Question Than “Do I Need BHRT?”

If your energy, sleep, libido, body composition, or recovery has changed, the first goal isn’t to prove you need hormones. It is to understand why you feel different.

For some patients, that investigation will identify a clinically relevant hormonal deficiency or menopausal transition that makes hormone therapy reasonable. For others, it may uncover anemia, thyroid dysfunction, metabolic disease, sleep-disordered breathing, shift work disorder, medication effects, inadequate recovery, or another treatable cause.

The right plan follows the diagnosis.

Schedule an Integrated Evaluation

If persistent fatigue, poor sleep, libido changes, or slow recovery are affecting work, training, or family life, an integrated evaluation can connect the medical, metabolic, sleep, nutritional, and musculoskeletal pieces. Dr. Cardenas and Dr. Jimenez work collaboratively so testing, risk screening, rehabilitation, and treatment decisions stay coordinated with your broader healthcare team.

Bring your medication list, supplements, recent laboratory results, work schedule, sleep pattern, and questions. The goal is not to sell a hormone. It is to help you understand the evidence and decide what care, if any, fits your health priorities.

---

References

American Academy of Sleep Medicine. (2025). Management of shift work disorder: An American Academy of Sleep Medicine clinical practice guideline.

American College of Obstetricians and Gynecologists. (2023). Compounded bioidentical menopausal hormone therapy. Obstetrics & Gynecology, 142, 1266–1273. Reaffirmed 2026.

Bhasin, S., Brito, J. P., Cunningham, G. R., Hayes, F. J., Hodis, H. N., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., Wu, F. C., & Yialamas, M. A. (2018). Testosterone therapy in men with hypogonadism: An Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism, 103(5), 1715–1744.

Endocrine Society. (2026, July 16). Statement on testosterone replacement therapy.

National Heart, Lung, and Blood Institute. (2025, December 18). Anemia diagnosis.

National Institute of Diabetes and Digestive and Kidney Diseases. (2017, May). Thyroid tests.

U.S. Food and Drug Administration. (2026). Compounding and the FDA: Questions and answers.